Clínica Baviera, S.A.

MCE CBAV.MC

Clínica Baviera, S.A. EPS (Diluted) for the year ending December 31, 2023: USD 2.44

Clínica Baviera, S.A. EPS (Diluted) is USD 2.44 for the year ending December 31, 2023, a 25.96% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Clínica Baviera, S.A. EPS (Diluted) for the year ending December 31, 2022 was USD 1.94, a 1.26% change year over year.
Clínica Baviera, S.A. EPS (Diluted) for the year ending December 31, 2021 was USD 1.91, a 82.04% change year over year.
Clínica Baviera, S.A. EPS (Diluted) for the year ending December 31, 2020 was USD 1.05, a 20.02% change year over year.
Clínica Baviera, S.A. EPS (Diluted) for the year ending December 31, 2019 was USD 0.88, a 4.77% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

MCE: CBAV.MC

Clínica Baviera, S.A.

CEO	Mr. Eduardo Baviera Sabater
IPO Date	April 3, 2007
Location	Spain
Headquarters	Paseo de la Castellana 20
Employees	1,326
Sector	Consumer Discretionary
Industries Eyewear Dental Care Drugstores & Retail Pharmacies

Description

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Austria, and Italy. The company is based in Madrid, Spain.

Key trends

Past 5 years